Histologic features and MIB-1/Ki67 indices in atypical meningiomas (GII WHO)

被引:0
|
作者
Jozefowicz, Mateusz [1 ]
Papierz, Wielislaw [1 ]
机构
[1] Zaklad Patomorfol Katedry Patomorfol Uniw Medyczn, Ul Pomorska 251, PL-92213 Lodz, Poland
来源
AKTUALNOSCI NEUROLOGICZNE | 2012年 / 12卷 / 02期
关键词
atypical meningiomas; benign meningiomas; histologic features; proliferative index;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Atypical meningiomas are defined according WHO criteria as tumours characterized by: increased mitotic activity or three or more of the following histologic features: increased cellularity, small cells with a high nuclear/cytoplasmic ratio, prominent nucleoli, patternless or sheet like growth, and foci of "spontaneous" or "geographic" necrosis. It means, that those meningiomas which reveal only one or even two from above mentioned features are, according to WHO classification, still consistent with diagnosis of benign (GI WHO) tumours. Histologic slices from 65 atypical meningiomas were investigated and presence of each from those diagnostic histologic criteria which were mentioned above, were taken to account. Additionally, in the same way 59 benign meningiomas, which showed one or two histologic features characteristic for atypical type of the tumours, were analysed. In all cases immunohistochemical reaction with MIB-1 antibody was carried out and proliferating indices (PI) were established using image analysis computer system. Correlation between histologic criteria for atypical meningiomas and proliferating indices of the tumours was statistically estimated. We found a significant relationship between PI and mitotic activity, necrosis, small cells changes, patternless growth, nucleolies and number of histologic features that tumors present.
引用
收藏
页码:104 / 128
页数:25
相关论文
共 50 条
  • [1] Ki67/MIB-1 Proliferation index in meningiomas
    Brodhun, M.
    Thomas, M.
    Lehrmann, K.
    Patt, S.
    HISTOPATHOLOGY, 2008, 53 : 313 - 314
  • [2] Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas
    Langford, LA
    Cooksley, CS
    DeMonte, F
    HUMAN PATHOLOGY, 1996, 27 (04) : 350 - 354
  • [3] Ki-67/MIB-1 immunostaining in human meningiomas
    Skjulsvik, A. J.
    Kepka, A.
    Torp, S. H.
    VIRCHOWS ARCHIV, 2014, 465 : S256 - S256
  • [4] Diagnostic Value of Protein Ki67 (MIB-1) in Atypical Pap Smears of Postmenopausal Women
    Fakhrjou, Ashraf
    Dastranj-Tabrizi, Ali
    Ghojazadeh, Morteza
    Ghorashi, Sona
    Velayati, Atefeh
    Piri, Reza
    Vahedi, Amir
    Sayyah-Melli, Manizhe
    Smaeili, Heydar-Ali
    Bonakdari, Amir
    Halimi, Monireh
    Naghavi-Behzad, Mohammad
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (08) : 4815 - 4818
  • [5] Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas
    Torp, SH
    Lindboe, CF
    Gronberg, BH
    Lydersen, S
    Sundstrom, S
    CLINICAL NEUROPATHOLOGY, 2005, 24 (04) : 170 - 174
  • [6] Correlation Between Digital and Manual Determinations of Ki-67/MIB-1 Proliferative Indices in Human Meningiomas
    Duc-Tien Pham
    Skaland, Ivar
    Winther, Theo L.
    Salvesen, Oyvind
    Torp, Sverre H.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2020, 28 (03) : 273 - 279
  • [7] Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas
    Abramovich, CM
    Prayson, RA
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1999, 123 (09) : 793 - 800
  • [8] MIB-1 (Ki-67) labeling indices in 261 consecutive gliomas
    Prok, AL
    Prayson, RA
    Barnett, GH
    MODERN PATHOLOGY, 2002, 15 (01) : 301A - 301A
  • [9] MIB-1 (Ki-67) labeling indices in 261 consecutive gliomas
    Prok, AL
    Prayson, RA
    Barnett, GH
    LABORATORY INVESTIGATION, 2002, 82 (01) : 301A - 301A
  • [10] The significance of Ki-67/MIB-1 labeling index in human meningiomas: A literature study
    Abry, Ellen
    Thomassen, Ingrid O.
    Salvesen, Oyvind O.
    Torp, Sverre H.
    PATHOLOGY RESEARCH AND PRACTICE, 2010, 206 (12) : 810 - 815